共 33 条
- [1] Vanhaesebroeck B., Waterfield M.D., Signaling by distinct classes of phosphoinositide 3-kinases, Exp. Cell Res, 253, pp. 239-254, (1999)
- [2] Blume-Jensen P., Hunter T., Oncogenic kinase signalling, Nature, 411, pp. 355-365, (2001)
- [3] Vivanco I., Sawyers C.L., The phosphatidylinositol 3-kinase AKT pathway in human cancer, Nature Rev. Cancer, 2, pp. 489-501, (2002)
- [4] Engelman J.A., Luo J., Cantley L.C., The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism, Nature Rev. Genet, 7, pp. 606-619, (2006)
- [5] Liu Z., Roberts T.M., Human tumor mutants in the p110α subunit of PI3K, Cell Cycle, 5, pp. 675-677, (2006)
- [6] Foukas L.C., Et al., Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation, Nature, 441, pp. 366-370, (2006)
- [7] Knight Z.A., Et al., A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling, Cell, 125, pp. 733-747, (2006)
- [8] Zhao J.J., Et al., The p110α isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation, Proc. Natl Acad. Sci. USA, 103, pp. 16296-16300, (2006)
- [9] Bader A.G., Kang S., Zhao L., Vogt P.K., Oncogenic PI3K deregulates transcription and translation, Nature Rev. Cancer, 5, pp. 921-929, (2005)
- [10] Vanhaesebroeck B., Et al., Synthesis and function of 3-phosphorylated inositol lipids, Annu. Rev. Biochem, 70, pp. 535-602, (2001)